AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PureTech Health plc

Transaction in Own Shares Nov 3, 2022

4932_rns_2022-11-03_dcfd7103-37ee-4326-b3be-c324b7a2186e.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 1363F

PureTech Health PLC

03 November 2022

3 November 2022

PureTech Health plc

Transaction in Own Shares

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

Date of purchase: 2 November 2022
Number of ordinary shares purchased: 19,275
Highest price paid per share: 248.50p
Lowest price paid per share: 243.50p
Volume weighted average price paid per share: 248.45p

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 10,324,939 ordinary shares in treasury and has 278,755,603 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 278,755,603, which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders. This pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 27 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization and a third that is expected to be filed soon for FDA approval, as of the date of PureTech's most recently filed Half-Year Report and corresponding Form 6-K. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on unique insights in immunology and drug development.

For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.

Contact:

PureTech

Investor Relations

[email protected]

Individual Transactions

Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
02/11/2022 14:44:09 353 248.5 XLON 00324654062TRLO1.1.1
02/11/2022 14:42:12 193 248.5 XLON 00324653092TRLO1.1.1
02/11/2022 14:42:12 405 248.5 XLON 00324653093TRLO1.1.1
02/11/2022 14:42:12 177 248.5 XLON 00324653090TRLO1.1.1
02/11/2022 14:42:12 212 248.5 XLON 00324653091TRLO1.1.1
02/11/2022 14:42:12 228 248.5 XLON 00324653089TRLO1.1.1
02/11/2022 14:42:12 338 248.5 XLON 00324653088TRLO1.1.1
02/11/2022 14:42:12 329 248.5 XLON 00324653087TRLO1.1.1
02/11/2022 14:42:11 327 248.5 XLON 00324653083TRLO1.1.1
02/11/2022 14:42:10 37 248.5 XLON 00324653080TRLO1.1.1
02/11/2022 14:42:10 352 248.5 XLON 00324653078TRLO1.1.1
02/11/2022 14:42:10 388 248.5 XLON 00324653079TRLO1.1.1
02/11/2022 14:42:10 223 248.5 XLON 00324653077TRLO1.1.1
02/11/2022 14:41:47 163 248.5 XLON 00324652827TRLO1.1.1
02/11/2022 14:41:13 337 248.5 XLON 00324652600TRLO1.1.1
02/11/2022 14:07:17 374 248.5 XLON 00324638197TRLO1.1.1
02/11/2022 14:07:17 385 248.5 XLON 00324638196TRLO1.1.1
02/11/2022 14:07:17 23 248.5 TRQX 00324638194TRLO1.1.1
02/11/2022 14:07:17 23 248.5 TRQX 00324638195TRLO1.1.1
02/11/2022 14:07:17 55 248.5 CHIX 00324638193TRLO1.1.1
02/11/2022 14:07:17 69 248.5 BATE 00324638191TRLO1.1.1
02/11/2022 14:07:17 69 248.5 BATE 00324638192TRLO1.1.1
02/11/2022 13:52:54 135 248.5 XLON 00324632057TRLO1.1.1
02/11/2022 13:48:01 48 248.5 CHIX 00324629186TRLO1.1.1
02/11/2022 13:45:33 21 248.5 TRQX 00324628110TRLO1.1.1
02/11/2022 13:43:23 22 248.5 TRQX 00324626985TRLO1.1.1
02/11/2022 13:43:20 59 248.5 CHIX 00324626973TRLO1.1.1
02/11/2022 13:43:20 81 248.5 BATE 00324626972TRLO1.1.1
02/11/2022 13:40:52 79 248.5 XLON 00324625766TRLO1.1.1
02/11/2022 13:40:52 75 248.5 XLON 00324625765TRLO1.1.1
02/11/2022 13:40:52 149 248.5 XLON 00324625764TRLO1.1.1
02/11/2022 13:40:52 100 248.5 XLON 00324625763TRLO1.1.1
02/11/2022 13:38:06 324 248 XLON 00324623956TRLO1.1.1
02/11/2022 13:37:23 85 248 BATE 00324623452TRLO1.1.1
02/11/2022 13:37:14 26 248 AQXE 00324623385TRLO1.1.1
02/11/2022 13:36:13 54 248 CHIX 00324622896TRLO1.1.1
02/11/2022 13:35:12 26 248.5 AQXE 00324622161TRLO1.1.1
02/11/2022 13:35:12 24 248.5 AQXE 00324622162TRLO1.1.1
02/11/2022 13:35:12 24 248.5 AQXE 00324622159TRLO1.1.1
02/11/2022 13:35:12 27 248.5 AQXE 00324622160TRLO1.1.1
02/11/2022 13:35:12 23 248.5 AQXE 00324622158TRLO1.1.1
02/11/2022 13:35:12 391 248.5 XLON 00324622157TRLO1.1.1
02/11/2022 13:35:12 396 248.5 XLON 00324622155TRLO1.1.1
02/11/2022 13:35:12 335 248.5 XLON 00324622156TRLO1.1.1
02/11/2022 13:35:12 340 248.5 XLON 00324622154TRLO1.1.1
02/11/2022 13:35:12 47 248.5 CHIX 00324622152TRLO1.1.1
02/11/2022 13:35:12 51 248.5 CHIX 00324622153TRLO1.1.1
02/11/2022 13:35:12 51 248.5 CHIX 00324622151TRLO1.1.1
02/11/2022 13:35:12 73 248.5 BATE 00324622150TRLO1.1.1
02/11/2022 13:35:12 73 248.5 BATE 00324622149TRLO1.1.1
02/11/2022 13:35:12 328 248.5 XLON 00324622148TRLO1.1.1
02/11/2022 13:35:12 328 248.5 XLON 00324622147TRLO1.1.1
02/11/2022 13:35:12 72 248.5 BATE 00324622145TRLO1.1.1
02/11/2022 13:35:12 81 248.5 BATE 00324622144TRLO1.1.1
02/11/2022 13:35:12 19 248.5 TRQX 00324622143TRLO1.1.1
02/11/2022 13:35:12 19 248.5 TRQX 00324622140TRLO1.1.1
02/11/2022 13:35:12 19 248.5 TRQX 00324622141TRLO1.1.1
02/11/2022 13:35:12 19 248.5 TRQX 00324622142TRLO1.1.1
02/11/2022 13:35:12 19 248.5 TRQX 00324622138TRLO1.1.1
02/11/2022 13:35:12 19 248.5 TRQX 00324622139TRLO1.1.1
02/11/2022 13:35:12 57 248.5 CHIX 00324622136TRLO1.1.1
02/11/2022 13:35:12 57 248.5 CHIX 00324622137TRLO1.1.1
02/11/2022 13:35:12 56 248.5 CHIX 00324622135TRLO1.1.1
02/11/2022 13:35:12 72 248.5 BATE 00324622134TRLO1.1.1
02/11/2022 12:47:15 395 248.5 XLON 00324606504TRLO1.1.1
02/11/2022 12:47:15 373 248.5 XLON 00324606501TRLO1.1.1
02/11/2022 12:47:15 399 248.5 XLON 00324606502TRLO1.1.1
02/11/2022 12:47:15 354 248.5 XLON 00324606503TRLO1.1.1
02/11/2022 12:47:15 338 248.5 XLON 00324606500TRLO1.1.1
02/11/2022 12:47:15 377 248.5 XLON 00324606499TRLO1.1.1
02/11/2022 12:47:15 408 248.5 XLON 00324606497TRLO1.1.1
02/11/2022 12:47:15 327 248.5 XLON 00324606498TRLO1.1.1
02/11/2022 12:47:15 376 248.5 XLON 00324606495TRLO1.1.1
02/11/2022 12:47:15 399 248.5 XLON 00324606496TRLO1.1.1
02/11/2022 12:47:15 382 248.5 XLON 00324606493TRLO1.1.1
02/11/2022 12:47:15 368 248.5 XLON 00324606494TRLO1.1.1
02/11/2022 12:47:15 339 248.5 XLON 00324606492TRLO1.1.1
02/11/2022 12:47:15 114 248.5 XLON 00324606491TRLO1.1.1
02/11/2022 12:47:15 60 248 CHIX 00324606490TRLO1.1.1
02/11/2022 12:47:15 72 248 BATE 00324606489TRLO1.1.1
02/11/2022 12:47:15 78 248.5 BATE 00324606488TRLO1.1.1
02/11/2022 12:47:15 81 248.5 BATE 00324606487TRLO1.1.1
02/11/2022 12:47:15 48 248.5 CHIX 00324606485TRLO1.1.1
02/11/2022 12:47:15 55 248.5 CHIX 00324606484TRLO1.1.1
02/11/2022 12:47:15 81 248.5 BATE 00324606486TRLO1.1.1
02/11/2022 12:47:15 56 248.5 CHIX 00324606483TRLO1.1.1
02/11/2022 12:47:15 19 248.5 TRQX 00324606482TRLO1.1.1
02/11/2022 12:47:15 21 248.5 TRQX 00324606481TRLO1.1.1
02/11/2022 12:47:15 48 248.5 CHIX 00324606480TRLO1.1.1
02/11/2022 12:47:15 47 248.5 CHIX 00324606479TRLO1.1.1
02/11/2022 12:47:15 68 248.5 BATE 00324606478TRLO1.1.1
02/11/2022 12:47:15 68 248.5 BATE 00324606477TRLO1.1.1
02/11/2022 12:47:15 67 248.5 BATE 00324606476TRLO1.1.1
02/11/2022 12:47:15 78 248.5 BATE 00324606475TRLO1.1.1
02/11/2022 12:47:15 67 248.5 BATE 00324606473TRLO1.1.1
02/11/2022 12:47:15 72 248.5 BATE 00324606474TRLO1.1.1
02/11/2022 12:47:15 69 248.5 BATE 00324606472TRLO1.1.1
02/11/2022 12:47:15 20 248.5 TRQX 00324606471TRLO1.1.1
02/11/2022 12:47:15 21 248.5 TRQX 00324606468TRLO1.1.1
02/11/2022 12:47:15 20 248.5 TRQX 00324606469TRLO1.1.1
02/11/2022 12:47:15 23 248.5 TRQX 00324606470TRLO1.1.1
02/11/2022 12:47:15 21 248.5 TRQX 00324606467TRLO1.1.1
02/11/2022 12:47:15 21 248.5 TRQX 00324606466TRLO1.1.1
02/11/2022 12:47:15 19 248.5 TRQX 00324606465TRLO1.1.1
02/11/2022 12:47:15 19 248.5 TRQX 00324606464TRLO1.1.1
02/11/2022 12:47:15 19 248.5 TRQX 00324606463TRLO1.1.1
02/11/2022 12:47:15 79 248.5 BATE 00324606462TRLO1.1.1
02/11/2022 12:47:15 80 248.5 BATE 00324606461TRLO1.1.1
02/11/2022 12:47:15 70 248.5 BATE 00324606460TRLO1.1.1
02/11/2022 12:47:15 73 248.5 BATE 00324606459TRLO1.1.1
02/11/2022 12:47:15 73 248.5 BATE 00324606458TRLO1.1.1
02/11/2022 12:47:15 24 248.5 AQXE 00324606457TRLO1.1.1
02/11/2022 12:47:15 28 248.5 AQXE 00324606456TRLO1.1.1
02/11/2022 12:47:15 25 248.5 AQXE 00324606455TRLO1.1.1
02/11/2022 12:47:15 23 248.5 AQXE 00324606454TRLO1.1.1
02/11/2022 12:47:15 27 248.5 AQXE 00324606453TRLO1.1.1
02/11/2022 12:47:15 23 248.5 AQXE 00324606452TRLO1.1.1
02/11/2022 12:47:15 21 248.5 TRQX 00324606449TRLO1.1.1
02/11/2022 12:47:15 19 248.5 TRQX 00324606450TRLO1.1.1
02/11/2022 12:47:15 21 248.5 TRQX 00324606451TRLO1.1.1
02/11/2022 12:47:15 23 248.5 TRQX 00324606448TRLO1.1.1
02/11/2022 12:47:15 21 248.5 TRQX 00324606447TRLO1.1.1
02/11/2022 12:47:15 23 248.5 TRQX 00324606446TRLO1.1.1
02/11/2022 12:47:15 27 248.5 AQXE 00324606445TRLO1.1.1
02/11/2022 12:47:15 24 248.5 AQXE 00324606444TRLO1.1.1
02/11/2022 12:47:15 27 248.5 AQXE 00324606442TRLO1.1.1
02/11/2022 12:47:15 24 248.5 AQXE 00324606443TRLO1.1.1
02/11/2022 12:47:15 23 248.5 AQXE 00324606440TRLO1.1.1
02/11/2022 12:47:15 23 248.5 AQXE 00324606441TRLO1.1.1
02/11/2022 12:47:15 23 248.5 AQXE 00324606439TRLO1.1.1
02/11/2022 12:47:15 60 248.5 CHIX 00324606438TRLO1.1.1
02/11/2022 12:47:15 60 248.5 CHIX 00324606437TRLO1.1.1
02/11/2022 12:47:15 25 248.5 AQXE 00324606436TRLO1.1.1
02/11/2022 12:47:15 28 248.5 AQXE 00324606435TRLO1.1.1
02/11/2022 12:47:15 26 248.5 AQXE 00324606434TRLO1.1.1
02/11/2022 11:56:26 50 248.5 CHIX 00324592625TRLO1.1.1
02/11/2022 11:56:26 55 248.5 CHIX 00324592624TRLO1.1.1
02/11/2022 11:56:26 52 248.5 CHIX 00324592623TRLO1.1.1
02/11/2022 11:56:26 55 248.5 CHIX 00324592621TRLO1.1.1
02/11/2022 11:56:26 48 248.5 CHIX 00324592622TRLO1.1.1
02/11/2022 11:56:26 48 248.5 CHIX 00324592620TRLO1.1.1
02/11/2022 11:56:26 59 248.5 CHIX 00324592619TRLO1.1.1
02/11/2022 11:00:23 286 248.5 XLON 00324577126TRLO1.1.1
02/11/2022 10:59:35 34 248.5 BATE 00324576838TRLO1.1.1
02/11/2022 10:56:37 339 248.5 XLON 00324576029TRLO1.1.1
02/11/2022 10:56:37 77 248.5 BATE 00324576028TRLO1.1.1
02/11/2022 10:47:25 24 248.5 AQXE 00324573519TRLO1.1.1
02/11/2022 10:42:54 20 247.5 CHIX 00324572342TRLO1.1.1
02/11/2022 10:42:54 22 248 TRQX 00324572341TRLO1.1.1
02/11/2022 10:42:32 18 247.5 CHIX 00324572232TRLO1.1.1
02/11/2022 10:42:32 16 247.5 CHIX 00324572233TRLO1.1.1
02/11/2022 10:41:40 370 247.5 XLON 00324572028TRLO1.1.1
02/11/2022 10:40:13 22 248.5 TRQX 00324571613TRLO1.1.1
02/11/2022 10:40:13 53 248.5 CHIX 00324571612TRLO1.1.1
02/11/2022 10:40:13 369 248.5 XLON 00324571611TRLO1.1.1
02/11/2022 10:40:13 24 248.5 AQXE 00324571609TRLO1.1.1
02/11/2022 10:40:13 86 248.5 BATE 00324571610TRLO1.1.1
02/11/2022 10:40:13 24 248.5 AQXE 00324571608TRLO1.1.1
02/11/2022 09:54:05 25 248.5 AQXE 00324555167TRLO1.1.1
02/11/2022 09:44:17 23 247.5 AQXE 00324552258TRLO1.1.1
02/11/2022 09:44:17 150 248 XLON 00324552257TRLO1.1.1
02/11/2022 09:44:17 233 248 XLON 00324552256TRLO1.1.1
02/11/2022 09:42:20 19 243.5 TRQX 00324551871TRLO1.1.1

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSFLFITLVLFIIF

Talk to a Data Expert

Have a question? We'll get back to you promptly.